Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 77INDUSTRY 22NIH 7OTHER_GOV 3NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

NET 2Endocrine 2Sarcoma 1Myeloid 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 18Prostatic Neoplasms 15Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Multiple Myeloma 10Melanoma 9Pancreatic Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Leukemia, Myeloid, Acute 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lung Neoplasms 5Hodgkin Disease 5Sarcoma 4Ovarian Neoplasms 4Osteosarcoma 4Hematologic Neoplasms 4Brain Neoplasms 4Teratoma 3Smoldering Multiple Myeloma 3Small Cell Lung Carcinoma 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Neoplasm Metastasis 3Malignant Solid Neoplasm 3HIV Infections 3Fallopian Tube Neoplasms 3Colonic Neoplasms 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Neuroendocrine Tumors × Clear all
NCT02402244 2026-05-05

Project: Every Child for Younger Patients With Cancer

Children's Oncology Group

Recruiting
75,000 enrolled
CNSDermatologicEndocrineLymphoidMyeloidNETSarcoma

Carcinoma in Situ, Ganglioneuroma, Lymphoproliferative Disorders, Melanoma, Myeloproliferative Disorders, Neoplasms, Pheochromocytoma, Central Nervous System Neoplasms, Nephroma, Mesoblastic, Desmoid Tumors, Neuroendocrine Tumors

NCT06345079 2025-08-14

STOPNET

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting
78 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡